Random array sequencing of low-complexity libraries

• US 10,385,475 B2
• Filed: 08/28/2012
• Issued: 08/20/2019
• Est. Priority Date: 09/12/2011
• Status: Active Grant

• Current Assignee: Adaptive Biotechnologies Corp.
• Original Assignee: Adaptive Biotechnologies Corp.
• Inventors: Zheng, Jianbiao, Willis, Thomas, Faham, Malek
• Primary Examiner(s): Vivlemore, Tracy
• Assistant Examiner(s): Kaup, Sahana S
• Application Number:
  US13/596,581
• Publication Number:
  US 20130065768A1
• Time in Patent Office: 2,548 Days
• Field of Search: None
• CPC Class Codes: C12Q 1/6874 involving nucleic acid arrays, e.g. sequencing by hybridisation
• CPC Class Codes: C12Q 2525/155 incorporating/generating a new priming site
• CPC Class Codes: C12Q 2535/122 Massive parallel sequencing
• CPC Class Codes: C12Q 2565/543 characterised by the use of two or more capture oligonucleotide primers in concert, e.g. bridge amplification
• CPC Class Codes: C40B 20/00 Methods specially adapted for identifying library members
• CPC Class Codes: C40B 50/14 Solid phase synthesis, i.e. wherein one or more library building blocks are bound to a solid support during library creation; Particular methods of cleavage from the solid support

Abstract

The invention is directed to a method of sequencing low-complexity amplicons randomly arrayed at high density on a surface. Methods of the invention include preparing amplicons for sequencing by a sets of primers that ensure initial signals front different amplicons on the surface will be evenly distributed among the different nucleotides being added in a sequencing by synthesis operation.

Claims

1. A method of sequencing a template nucleic acid from a library of homologous template nucleic acids, the method comprising the steps of:

amplifying a library of homologous template nucleic acids from a sample, wherein each template nucleic acid from the library of homologous template nucleic acids is amplified with a set of forward primers and at least one reverse primer, wherein each forward primer in the set of forward primers has a 3′

region comprising a sequence complementary to a template nucleic acid from the library of homologous template nucleic acids and a 5′

tail, wherein the 5′

tail comprises a sequencing primer binding site and a set of wildcard nucleotides at its 3′

terminus comprising at least 1 wildcard nucleotide, and wherein the set of wildcard nucleotides is sandwiched between and located immediately adjacent to both the sequencing primer binding site and the 3′

region comprising the sequence complementary to the template nucleic acid, wherein the set of wildcard nucleotides in each forward primer in the set of forward primers is a different set of wildcard nucleotides from the wildcard nucleotides in each other forward primer in the set of forward primers, wherein the amplifying generates a plurality of amplicons for each template nucleic acid, wherein each amplicon from the plurality of amplicons for each template nucleic acid comprises a different set of wildcard nucleotides located between the sequencing primer binding site and sequence for the template nucleic acid;

randomly arraying the plurality of amplicons for each template nucleic acid of the library of homologous template nucleic acids on a surface, thereby generating a random array of amplicons of homologous template nucleic acids; and

extending in a sequencing by synthesis reaction a sequencing primer annealed to the sequencing primer binding site present in each amplicon on the random array, wherein the extending generates sequence reads from each amplicon from the plurality of amplicons for each template nucleic acid that comprises a set of wildcard nucleotides that differs between sequence reads from each other amplicon from the plurality of amplicons for each template nucleic acid, wherein the set of wildcard nucleotides is the initial nucleotide(s) sequenced in the sequence reads from each amplicon.

2. The method of claim 1, wherein the library of homologous template nucleic acids is a population of recombined immune molecules.

3. The method of claim 2, wherein the population of recombined immune molecules is a population of nucleic acids encoding T cell receptors or fragments thereof or a population of nucleic acids encoding B cell receptors or fragments thereof.

4. The method of claim 3, wherein the recombined immune molecules are at least fifty percent homologous to one another.

5. The method of claim 1, wherein the set of wildcard nucleotides contains 1 wildcard nucleotide.

6. The method of claim 1, wherein the set of wildcard nucleotides contains 2 wildcard nucleotides.

7. The method of claim 1, wherein the set of wildcard nucleotides contains 3 wildcard nucleotides.

8. The method of claim 1, wherein the set of wildcard nucleotides contains 4 wildcard nucleotides.